First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1880
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)